{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:43:15Z","timestamp":1757619795461,"version":"3.44.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Cushing\u2019s syndrome is an uncommon but serious condition caused by long-term exposure to elevated cortisol levels, which is usually iatrogenic in origin. Although systemic corticosteroids are the most frequent agents, the association of intranasal corticosteroids with this condition is remarkably rare.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>This report is about a 21-year-old Iranian woman using betamethasone nasal drops for nasal obstruction. The patient presented with weight gain, Amenorrhea, mood disturbances, red purplish striae, and mild hirsutism. Hormonal assessments revealed suppression of the hypothalamic\u2013pituitary\u2013adrenal axis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This case demonstrates the underappreciated systemic effects of intranasal betamethasone to induce Cushing\u2019s syndrome. It serves as a pivotal reminder of the need for vigilance in prescribing practices and reinforces the importance of early diagnosis to ensure favorable patient outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13256-025-05428-3","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T11:19:24Z","timestamp":1753442364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cushing\u2019s syndrome in a young woman due to prolonged betamethasone nasal drop use: a case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Mohammadsadra","family":"Shamohammadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delaram","family":"Eskandari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Ziaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Hossein","family":"Samadanifard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haleh","family":"Chehrehgosha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir Hossein","family":"Ghanooni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"issue":"3","key":"5428_CR1","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ando.2023.03.007","volume":"84","author":"J Cristante","year":"2023","unstructured":"Cristante J, Chabre O. Factitious, or iatrogenic but unexpected Cushing\u2019s syndrome. Ann Endocrinol (Paris). 2023;84(3):370\u20132.","journal-title":"Ann Endocrinol (Paris)"},{"issue":"9996","key":"5428_CR2","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","volume":"386","author":"A Lacroix","year":"2015","unstructured":"Lacroix A, Feelders RA, Stratakis CA, Nieman LK. Cushing\u2019s syndrome. Lancet. 2015;386(9996):913\u201327.","journal-title":"Lancet"},{"issue":"4","key":"5428_CR3","first-page":"511","volume":"16","author":"A Scutelnicu","year":"2020","unstructured":"Scutelnicu A, Panaitescu AM, Ciobanu AM, Gica N, Botezatu R, Peltecu G, et al. Iatrogenic cushing\u2019s syndrome as a consequence of nasal use of betamethasone spray during pregnancy. Acta Endocrinol. 2020;16(4):511\u20137.","journal-title":"Acta Endocrinol"},{"issue":"4","key":"5428_CR4","first-page":"161","volume":"41","author":"M Sakamoto","year":"2018","unstructured":"Sakamoto M, Morita K, Okamura E, Uchino T, Okamoto K, Ozawa Y, et al. A case of iatrogenic cushing syndrome due to overuse of nasal steriod and concurrent administration of clarithromycin. Teikyo Med J. 2018;41(4):161\u20138.","journal-title":"Teikyo Med J"},{"issue":"834","key":"5428_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1136\/pgmj.71.834.231","volume":"71","author":"CM Nutting","year":"1995","unstructured":"Nutting CM, Page SR. Iatrogenic Cushing\u2019s syndrome due to nasal betamethasone: a problem not to be sniffed at! Postgrad Med J. 1995;71(834):231\u20132.","journal-title":"Postgrad Med J"},{"issue":"3","key":"5428_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1017\/S0022215100104566","volume":"102","author":"DJ Stevens","year":"1988","unstructured":"Stevens DJ. Cushing\u2019s syndrome due to the abuse of betamethasone nasal drops. J Laryngol Otol. 1988;102(3):219\u201321.","journal-title":"J Laryngol Otol"},{"key":"5428_CR7","first-page":"13","volume":"2013","author":"A Dow","year":"2013","unstructured":"Dow A, Yu R, Carmichael J. Too little or too much corticosteroid? Coexisting adrenal insufficiency and Cushing\u2019s syndrome from chronic, intermittent use of intranasal betamethasone. Endocrinol Diabetes Metab Case Rep. 2013;2013:13\u20130036.","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"3","key":"5428_CR8","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.jaip.2020.11.017","volume":"9","author":"C Bachert","year":"2021","unstructured":"Bachert C, Desrosiers MY, Hellings PW, Laidlaw TM. The role of biologics in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract. 2021;9(3):1099\u2013106.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"5428_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jaci.2020.11.013","volume":"147","author":"C Bachert","year":"2021","unstructured":"Bachert C, Han JK, Wagenmann M, Hosemann W, Lee SE, Backer V, et al. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management. J Allergy Clin Immunol. 2021;147(1):29\u201336.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"5428_CR10","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1001\/archinte.158.3.294","volume":"158","author":"S Quddusi","year":"1998","unstructured":"Quddusi S, Browne P, Toivola B, Hirsch IB. Cushing syndrome due to surreptitious glucocorticoid administration. Arch Intern Med. 1998;158(3):294\u20136.","journal-title":"Arch Intern Med"},{"issue":"S1","key":"5428_CR11","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1002\/alr.22331","volume":"9","author":"JW Grayson","year":"2019","unstructured":"Grayson JW, Harvey RJ. Topical corticosteroid irrigations in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2019;9(S1):S9\u201315.","journal-title":"Int Forum Allergy Rhinol"},{"issue":"5","key":"5428_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.7453\/gahmj.2013.008","volume":"2","author":"JJ Gagnier","year":"2013","unstructured":"Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D. The CARE guidelines: consensus-based clinical case reporting guideline development. Global Adv Health Med. 2013;2(5):38\u201343.","journal-title":"Global Adv Health Med"},{"issue":"11","key":"5428_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11882-020-00960-2","volume":"20","author":"J McDonnell","year":"2020","unstructured":"McDonnell J, Weller K, Pien LC. Safety of intranasal steroids: an updated perspective. Curr Allergy Asthma Rep. 2020;20(11):69.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"s62","key":"5428_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1034\/j.1398-9995.2000.055suppl62019.x","volume":"55","author":"GK Scadding","year":"2000","unstructured":"Scadding GK. Other anti-inflammatory uses of intranasal corticosteroids in upper respiratory inflammatory diseases. Allergy. 2000;55(s62):19\u201323.","journal-title":"Allergy"},{"issue":"4","key":"5428_CR15","first-page":"Cd011993","volume":"4","author":"LY Chong","year":"2016","unstructured":"Chong LY, Head K, Hopkins C, Philpott C, Burton MJ, Schilder AG. Different types of intranasal steroids for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016;4(4):Cd011993.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7160","key":"5428_CR16","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1136\/bmj.317.7160.739","volume":"317","author":"CA Findlay","year":"1998","unstructured":"Findlay CA, Macdonald JF, Wallace AM, Geddes N, Donaldson MD. Childhood Cushing\u2019s syndrome induced by betamethasone nose drops, and repeat prescriptions. BMJ. 1998;317(7160):739\u201340.","journal-title":"BMJ"},{"key":"5428_CR17","doi-asserted-by":"crossref","first-page":"A275","DOI":"10.1136\/archdischild-2018-315064","volume":"104","author":"C Reynolds","year":"2019","unstructured":"Reynolds C, Agrawal P, McCann A, O\u2019Sullivan T, Chroinin MN, O\u2019Riordan SMP. Cushing syndrome and adrenal insufficiency induced by high dose prolonged intranasal betamethasone. Arch Dis Child. 2019;104:A275.","journal-title":"Arch Dis Child"},{"key":"5428_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.11604\/pamj.2014.17.237.3332","volume":"17","author":"IO Oluwayemi","year":"2014","unstructured":"Oluwayemi IO, Oduwole AO, Oyenusi E, Onyiriuka AN, Abdullahi M, Fakeye-Udeogu OB, et al. Iatrogenic Cushing\u2019s syndrome in children following nasal steroid. Pan Afr Med J. 2014;17:237.","journal-title":"Pan Afr Med J"},{"issue":"1","key":"5428_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/adc.87.1.45","volume":"87","author":"RJ Perry","year":"2002","unstructured":"Perry RJ, Findlay CA, Donaldson MDC. Cushing\u2019s syndrome, growth impairment, and occult adrenal suppression associated with intranasal steroids. Arch Dis Child. 2002;87(1):45\u20138.","journal-title":"Arch Dis Child"},{"key":"5428_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2019.101828","volume":"58","author":"MG Matera","year":"2019","unstructured":"Matera MG, Rinaldi B, Calzetta L, Rogliani P, Cazzola M. Pharmacokinetics and pharmacodynamics of inhaled corticosteroids for asthma treatment. Pulm Pharmacol Ther. 2019;58: 101828.","journal-title":"Pulm Pharmacol Ther"},{"issue":"2","key":"5428_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10928-020-09730-z","volume":"48","author":"W Krzyzanski","year":"2021","unstructured":"Krzyzanski W, Milad MA, Jobe AH, Peppard T, Bies RR, Jusko WJ. Population pharmacokinetic modeling of intramuscular and oral dexamethasone and betamethasone in Indian women. J Pharmacokinet Pharmacodyn. 2021;48(2):261\u201372.","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"11","key":"5428_CR22","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1210\/clinem\/dgac492","volume":"107","author":"M Savas","year":"2022","unstructured":"Savas M, Mehta S, Agrawal N, van Rossum EFC, Feelders RA. Approach to the patient: diagnosis of Cushing syndrome. J Clin Endocrinol Metab. 2022;107(11):3162\u201374.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"5428_CR23","doi-asserted-by":"publisher","first-page":"511","DOI":"10.4183\/aeb.2020.511","volume":"16","author":"A Scutelnicu","year":"2020","unstructured":"Scutelnicu A, Panaitescu AM, Ciobanu AM, Gica N, Botezatu R, Peltecu G, et al. Iatrogenic Cushing\u2019s syndrome as a consequence of nasal use of betamethasone spray during pregnancy. Acta Endocrinol (Buchar). 2020;16(4):511\u20137.","journal-title":"Acta Endocrinol (Buchar)"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05428-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-025-05428-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05428-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:01:34Z","timestamp":1757289694000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-025-05428-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5428"],"URL":"https:\/\/doi.org\/10.1186\/s13256-025-05428-3","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with ethical guidelines and was approved by the Research Ethics Committee of Iran University of Medical Sciences under approval number IR.IUMS.REC.1404.208.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"366"}}